StockNews.AI
DBCCF
StockNews.AI
210 days

Decibel Announces Stock Option Grants

1. Decibel granted 21.9 million stock options to management and employees. 2. Options exercise prices are $0.13 and $0.075 per share. 3. Vesting includes immediate and staggered installments over three years. 4. Decibel expands reach with EU-GMP-certified facilities post AgMedica acquisition. 5. Company focuses on premium cannabis products and global market growth.

5m saved
Insight
Article

FAQ

Why Bullish?

Stock option grants can enhance employee retention, potentially improving company performance. Similar past grants in cannabis companies have led to positive market reactions.

How important is it?

The stock option grant is significant for Decibel's operations, influencing employee engagement. However, broader market conditions will also play a critical role.

Why Long Term?

The vesting schedule extends through 2028, indicating sustained incentives for employees. Long-term retention often aligns with growth in market value overtime.

Related Companies

DBAGMD
CALGARY, AB, Jan. 21, 2025 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured products, announces that it has granted an aggregate of 21,915,974 stock options (each, an "Option") to certain officers and employees of the Company in accordance with the Company's stock option plan. Each Option is exercisable for one common share in the capital of the Company (a "Share") at a price of either $0.13 or $0.075 per Share, depending on the grant. This is a normal-course grant that comprises part of the long-term compensation and employee retention incentives program provided by the Company. One tranche of the Options will vest as of the date hereof, while the remaining tranches will vest in three equal nine (9) month installments commencing on October 21, 2025, with all of the Options expiring on January 21, 2028. About Decibel Decibel is a consumer-focused cannabis company known for premium products that delight customers through innovation and quality. With brands like General Admission, Qwest, and Vox, Decibel's offerings are available across Canada, with expanding reach into global markets. Following the acquisition of AgMedica Biosciences in Q4 2024, Decibel has added an EU-GMP-certified facility, supporting its commitment to international standards and global distribution growth. Decibel now operates three cultivation facilities and a processing and manufacturing center, positioning the company as a leader in high-quality, globally accessible cannabis products and brands. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation, including statements that relate to Decibel's business plans generally, and specifically the creation of a global footprint and ability to delight customers through a commitment to robust innovation and product quality. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, the Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.  Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Many of these risks and uncertainties and additional risk factors generally applicable to the Company are described in the Company's management's discussion and analysis for the three and nine months ended September 30, 2024 and 2023, which are available under the Company's profile at www.sedarplus.ca. SOURCE Decibel Cannabis Company Inc.

Related News